NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.82 +0.34 (+0.43%) GOLD FUTURES
2,322.30 -8.90 (-0.38%) DOW
38,901.74 +49.47 (+0.13%) Bitcoin GBP
50,860.09 +223.55 (+0.44%)
GH Jan 2025 50.000 put
| Previous close | 28.58 |
| Open | 28.70 |
| Bid | 20.80 |
| Ask | 23.50 |
| Strike | 50.00 |
| Expiry date | 2025-01-17 |
| Day's range | 28.58 - 28.70 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
Business WireGuardant Health Surpasses 500 Peer-Reviewed Publications Milestone
PALO ALTO, Calif., May 07, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its achievement of surpassing a significant milestone of 500 peer-reviewed publications featuring its technology in esteemed scientific journals. This milestone highlights Guardant Health’s leadership, amassing one of the most robust portfolios of relevant liquid biopsy research studies in the industry.
ZacksCurious about Guardant Health (GH) Q1 Performance? Explore Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Guardant Health (GH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
ZacksWant Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
